Three-dimensional conformal radiotherapy and dose escalation: Where do we stand?

Seminars in Radiation Oncology - Tập 8 - Trang 107-114 - 1998
Michael J. Zelefsky1,2, Steven A. Leibel1,2, Gerald J. Kutcher1,2, Zvi Fuks3,2
1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
2Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Tài liệu tham khảo

Scardino, 1986, The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer, J Urol, 135, 510, 10.1016/S0022-5347(17)45712-0 Sewell, 1975, Extended biopsy follow-up after full course radiation for resectable prostatic carcinoma, J Urol, 113, 371, 10.1016/S0022-5347(17)59484-7 Crook, 1995, Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patients, Urology, 45, 625, 10.1016/S0090-4295(99)80054-5 Laverdiere, 1997, Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer, Int J Radiat Oncol Biol Phys, 37, 247, 10.1016/S0360-3016(96)00513-5 Fuks, 1991, The effect of local control on metastatic dissemination carcinoma of the prostate: Long-term results in patients treated with 125-I implantation, Int J Radiat Oncol Biol Phys, 21, 537, 10.1016/0360-3016(91)90668-T Kuban, 1995, Potential benefit of improved local tumor control in patient with prostate carcinoma, Cancer, 75, 2373, 10.1002/1097-0142(19950501)75:9<2373::AID-CNCR2820750930>3.0.CO;2-2 Shipley, 1995, Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal prostons compared with conventional dose irradiation using photons alone, Int J Radiat Oncol Biol Phys, 32, 3, 10.1016/0360-3016(95)00063-5 Hanks, 1996, Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/mL, Int J Radiat Oncol Biol Phys, 35, 862, 10.1016/0360-3016(96)00207-6 Roach, 1996, Radiotherapy for high grade clinically localized adenocarcinoma of the prostate, J Urol, 156, 1719, 10.1016/S0022-5347(01)65490-9 Pollack A, Zagars GK: External beam radiotherapy dose-response of prostate cancer. Int J Radiat Oncol Biol Phys (in press) Hanks, 1988, The effect of dose on local control of prostate cancer, Int J Radiat Oncol Biol Phys, 15, 1299, 10.1016/0360-3016(88)90224-6 Smit, 1990, Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose, Int J Radiat Oncol Biol Phys, 18, 23, 10.1016/0360-3016(90)90262-I Leibel, 1994, The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate, Semin Oncol, 21, 580 Zelefsky, 1995, The feasibility of dose escalation with three-dimensional conformal radio-therapy in patients with prostatic carcinoma, Cancer J Sci Am, 1, 42 Sandler, 1996, Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients, Int J Radiat Oncol Biol Phys, 34, 655 Vijaykumar, 1993, Acute toxicity during external beam radiotherapy for localized prostate cancer: Comparison of different techniques, Int J Radiat Oncol Biol Phys, 25, 359, 10.1016/0360-3016(93)90361-X Forman, 1996, Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: Results of a dose escalation study, Int J Radiat Oncol Biol Phys, 34, 655, 10.1016/0360-3016(95)02202-3 Schultheiss, 1995, Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate, Int J Radiat Oncol Biol Phys, 32, 643, 10.1016/0360-3016(95)00149-S Zelefsky, 1997, The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy, Int J Radiat Oncol Biol Phys, 37, 13, 10.1016/S0360-3016(96)00460-9 Pollack, 1996, Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity, Int J Radiat Oncol Biol Phys, 34, 555, 10.1016/0360-3016(95)02103-5 Pickett, 1995, The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer, Int J Radiat Oncol Biol Phys, 32, 211, 10.1016/0360-3016(95)00512-W Ling, 1996, Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with multileaf collimation, Int J Radiat Oncol Biol Phys, 35, 721, 10.1016/0360-3016(96)00174-5 Mohan, 1996, The potential of optimized intensity modulation to escalate prostate dose to 86.4 Gy, Int J Radiat Oncol Biol Phys, 36, 197, 10.1016/S0360-3016(97)85418-1 Lawton, 1991, Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706, Int J Radiat Oncol Biol Phys, 21, 935, 10.1016/0360-3016(91)90732-J Soffen, 1992, Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: A reduction in acute morbidity, Int J Radiat Oncol Biol Phys, 24, 485, 10.1016/0360-3016(92)91063-S Tait, 1997, Acute toxicity in pelvic radiotherapy: A randomized trial of conformal versus conventional treatment, Radiother Oncol, 42, 121, 10.1016/S0167-8140(96)01870-1 Zelefsky, 1988, Three-dimensional conformal radiation therapy in the management of localized prostate cancer, 215 Zelefsky, MJ, Leibel SA, Gaudin PB: Dose escalation with three-dimensional conformal radiotherapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys (in press) Lee, 1996, Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiotherapy for clinically localized prostate cancer: Further evidence of a significant dose effect, Int J Radiat Oncol Biol Phys, 35, 251, 10.1016/0360-3016(96)00064-8 Zelefsky, 1994, Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy, Int J Radiat Oncol Biol Phys, 29, 755, 10.1016/0360-3016(94)90563-0 Zelefsky, 1997, Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy, Urology, 49, 38, 10.1016/S0090-4295(97)00168-4 Forman, 1995, Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: Effects on the volume of normal tissue irradiation, Cancer Invest, 13, 8, 10.3109/07357909509024889 Yang, 1995, The potential for normal tissue reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer, Int J Radiat Oncol Biol Phys, 33, 1009, 10.1016/0360-3016(95)02064-0 American Society for Therapeutic Radiology and Oncology Consensus Panel, 1997, Consensus statement: Guidelines for PSA following radiation therapy, Int J Radiat Oncol Biol Phys, 37, 1035